Regulation of innate immunity by NADPH oxidase

Free Radical Biology and Medicine

Volumn 53, Issue 1, 2012, Pages 72-80

  Segal, Brahm H ^a,b   Grimm, Melissa J ^a   Khan, A Nazmul H ^a   Han, Wei ^c   Blackwell, Timothy S ^c,d  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Chronic granulomatous disease; Inflammation; NADPH oxidase

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ACUTE LUNG INJURY; BACTERIAL INFECTION; CHRONIC GRANULOMATOUS DISEASE; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME MECHANISM; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW;

ANIMALS; HUMANS; IMMUNITY, INNATE; INFECTION; INFLAMMATION; MICE; NADPH OXIDASE;

BACTERIA (MICROORGANISMS);

EID: 84861626190     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.04.022     Document Type: Review

References (132)

1. D.B. Kuhns, W.G. Alvord, T. Heller, J.J. Feld, K.M. Pike, B.E. Marciano, G. Uzel, S.S. DeRavin, D.A. Priel, and B.P. Soule Residual NADPH oxidase and survival in chronic granulomatous disease N. Engl. J. Med. 363 2010 2600 2610
2. D.B. Graham, C.M. Robertson, J. Bautista, F. Mascarenhas, M.J. Diacovo, V. Montgrain, S.K. Lam, V. Cremasco, W.M. Dunne, and R. Faccio Neutrophil-mediated oxidative burst and host defense are controlled by a Vav-PLCgamma2 signaling axis in mice J. Clin. Invest. 117 2007 3445 3452
3. A. Mocsai, M. Zhou, F. Meng, V.L. Tybulewicz, and C.A. Lowell Syk is required for integrin signaling in neutrophils Immunity 16 2002 547 558
4. B.N. Gantner, R.M. Simmons, S.J. Canavera, S. Akira, and D.M. Underhill Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2 J. Exp. Med. 197 2003 1107 1117
5. J.A. Van Ziffle, and C.A. Lowell Neutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infection Blood 114 2009 4871 4882
6. J.A. Winkelstein, M.C. Marino, R.B.J.r. Johnston, J. Boyle, J. Curnutte, J.I. Gallin, H.L. Malech, S.M. Holland, H. Ochs, and P. Quie Chronic granulomatous disease: report on a national registry of 368 patients Medicine (Baltimore) 79 2000 155 169
7. J.M. van den Berg, E. van Koppen, A. Ahlin, B.H. Belohradsky, E. Bernatowska, L. Corbeel, T. Espanol, A. Fischer, M. Kurenko-Deptuch, and R. Mouy Chronic granulomatous disease: the European experience PLoS ONE 4 2009 e5234
8. J.I. Gallin, D.W. Alling, H.L. Malech, R. Wesley, D. Koziol, B. Marciano, E.M. Eisenstein, M.L. Turner, E.S. DeCarlo, and J.M. Starling Itraconazole to prevent fungal infections in chronic granulomatous disease N. Engl. J. Med. 348 2003 2416 2422
9. S.J. Weiss, and A. Slivka Monocyte and granulocyte-mediated tumor cell destruction. A role for the hydrogen peroxide-myeloperoxidase-chloride system J. Clin. Invest 69 1982 255 262
10. W.M. Nauseef, M. Cogley, S. Bock, and P.E. Petrides Pattern of inheritance in hereditary myeloperoxidase deficiency associated with the R569W missense mutation J. Leukoc. Biol. 63 1998 264 269
11. W.M. Nauseef Myeloperoxidase deficiency Hematol. Oncol. Clin. North Am. 2 1988 135 158
12. B.H. Segal, N. Sakamoto, M. Patel, K. Maemura, A.S. Klein, S.M. Holland, and G.B. Bulkley Xanthine oxidase contributes to host defense against Burkholderia cepacia in the p47(phox-/-) mouse model of chronic granulomatous disease Infect. Immun. 68 2000 2374 2378
13. A.P. West, I.E. Brodsky, C. Rahner, D.K. Woo, H. Erdjument-Bromage, P. Tempst, M.C. Walsh, Y. Choi, G.S. Shadel, and S. Ghosh TLR signalling augments macrophage bactericidal activity through mitochondrial ROS Nature 472 2011 476 480
14. J.D. MacMicking, R.J. North, R. LaCourse, J.S. Mudgett, S.K. Shah, and C.F. Nathan Identification of nitric oxide synthase as a protective locus against tuberculosis Proc. Natl. Acad. Sci. USA 94 1997 5243 5248
15. A.M. Cooper, B.H. Segal, A.A. Frank, S.M. Holland, and I.M. Orme Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice Infect. Immun. 68 2000 1231 1234
16. B.H. Segal, L. Ding, and S.M. Holland Phagocyte NADPH oxidase, but not inducible nitric oxide synthase, is essential for early control of Burkholderia cepacia and chromobacterium violaceum infection in mice Infect. Immun 71 2003 205 210
17. M.U. Shiloh, J.D. MacMicking, S. Nicholson, J.E. Brause, S. Potter, M. Marino, F. Fang, M. Dinauer, and C. Nathan Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase Immunity 10 1999 29 38
18. B.M. Babior NADPH oxidase: an update Blood 93 1999 1464 1476
19. A.J. Thrasher, N.H. Keep, F. Wientjes, and A.W. Segal Chronic granulomatous disease Biochim. Biophys. Acta 1227 1994 1 24
20. E.P. Reeves, H. Lu, H.L. Jacobs, C.G. Messina, S. Bolsover, G. Gabella, E.O. Potma, A. Warley, J. Roes, and A.W. Segal Killing activity of neutrophils is mediated through activation of proteases by K flux Nature 416 2002 291 297
21. T.A. Fuchs, U. Abed, C. Goosmann, R. Hurwitz, I. Schulze, V. Wahn, Y. Weinrauch, V. Brinkmann, and A. Zychlinsky Novel cell death program leads to neutrophil extracellular traps J. Cell Biol. 176 2007 231 241
22. M. Bianchi, A. Hakkim, V. Brinkmann, U. Siler, R.A. Seger, A. Zychlinsky, and J. Reichenbach Restoration of NET formation by gene therapy in CGD controls aspergillosis Blood 114 2009 2619 2622
23. V. Brinkmann, U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, D.S. Weiss, Y. Weinrauch, and A. Zychlinsky Neutrophil extracellular traps kill bacteria Science 303 2004 1532 1535
24. R.R. Vethanayagam, N.G. Almyroudis, M.J. Grimm, D.C. Lewandowski, C.T. Pham, T.S. Blackwell, R. Petraitiene, V. Petraitis, T.J. Walsh, and C.F. Urban Role of NADPH oxidase versus neutrophil proteases in antimicrobial host defense PLoS ONE 6 2011 e28149
25. J. Bustamante, A.A. Arias, G. Vogt, C. Picard, L.B. Galicia, C. Prando, A.V. Grant, C.C. Marchal, M. Hubeau, and A. Chapgier Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease Nat. Immunol. 12 2011 213 221
26. A. Schaffner, H. Douglas, and A. Braude Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes J. Clin. Invest 69 1982 617 631
27. M.D. Kraaij, N.D. Savage, S.W. van der Kooij, K. Koekkoek, J. Wang, J.M. van den Berg, T.H. Ottenhoff, T.W. Kuijpers, R. Holmdahl, and C. van Kooten Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species Proc. Natl. Acad. Sci. USA 107 2010 17686 17691
28. K.A. Gelderman, M. Hultqvist, A. Pizzolla, M. Zhao, K.S. Nandakumar, R. Mattsson, and R. Holmdahl Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species J. Clin. Invest. 117 2007 3020 3028
29. A. Savina, C. Jancic, S. Hugues, P. Guermonprez, P. Vargas, I.C. Moura, A.M. Lennon-Dumenil, M.C. Seabra, G. Raposo, and S. Amigorena NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells Cell 126 2006 205 218
30. A.R. Mantegazza, A. Savina, M. Vermeulen, L. Perez, J. Geffner, O. Hermine, S.D. Rosenzweig, F. Faure, and S. Amigorena NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells Blood 112 2008 4712 4722
31. C. Jancic, A. Savina, C. Wasmeier, T. Tolmachova, J. El-Benna, P.M. Dang, S. Pascolo, M.A. Gougerot-Pocidalo, G. Raposo, and M.C. Seabra Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes Nat. Cell Biol. 9 2007 367 378
32. C.A. Corzo, M.J. Cotter, P. Cheng, F. Cheng, S. Kusmartsev, E. Sotomayor, T. Padhya, T.V. McCaffrey, J.C. McCaffrey, and D.I. Gabrilovich Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells J. Immunol. 182 2009 5693 5701
33. B.E. Marciano, S.D. Rosenzweig, D.E. Kleiner, V.L. Anderson, D.N. Darnell, S. Anaya-OBrien, D.M. Hilligoss, H.L. Malech, J.I. Gallin, and S.M. Holland Gastrointestinal involvement in chronic granulomatous disease Pediatrics 114 2004 462 468
34. J.I. Gallin, and E.S. Buescher Abnormal regulation of inflammatory skin responses in male patients with chronic granulomatous disease Inflammation 7 1983 227 232
35. S.H. Jackson, J.I. Gallin, and S.M. Holland The p47phox mouse knock-out model of chronic granulomatous disease J. Exp. Med. 182 1995 751 758
36. J.D. Pollock, D.A. Williams, M.A. Gifford, L.L. Li, X. Du, J. Fisherman, S.H. Orkin, C.M. Doerschuk, and M.C. Dinauer Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production Nat. Genet 9 1995 202 209
37. R.J. Johnson, W.G. Couser, C.E. Alpers, M. Vissers, M. Schulze, and S.J. Klebanoff The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo J. Exp. Med. 168 1988 1169 1174
38. A.M. Adkison, S.Z. Raptis, D.G. Kelley, and C.T. Pham Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis J. Clin. Invest. 109 2002 363 371
39. A.W. Ford-Hutchinson Leukotriene B4 in inflammation Crit. Rev. Immunol. 10 1990 1 12
40. C. Haslett, P.J. Jose, P.C. Giclas, T.J. Williams, and P.M. Henson Cessation of neutrophil influx in C5a-induced acute experimental arthritis is associated with loss of chemoattractant activity from the joint space J. Immunol. 142 1989 3510 3517
41. R.A. Clark, and S.J. Klebanoff Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system J. Clin. Invest. 64 1979 913 920
42. W.R. Henderson, and S.J. Klebanoff Leukotriene production and inactivation by normal, chronic granulomatous disease and myeloperoxidase- deficient neutrophils J. Biol. Chem. 258 1983 13522 13527
43. T. Hamasaki, T. Sakano, M. Kobayashi, N. Sakura, K. Ueda, and T. Usui Leukotriene B4 metabolism in neutrophils of patients with chronic granulomatous disease: phorbol myristate acetate decreases endogenous leukotriene B4 via NADPH oxidase-dependent mechanism Eur. J. Clin. Invest. 19 1989 404 411
44. B.H. Segal, D.B. Kuhns, L. Ding, J.I. Gallin, and S.M. Holland Thioglycollate peritonitis in mice lacking C5, 5-lipoxygenase, or p47(phox): complement, leukotrienes, and reactive oxidants in acute inflammation J. Leukoc. Biol. 71 2002 410 416
45. J.E. Petersen, T.S. Hiran, W.S. Goebel, C. Johnson, R.C. Murphy, F.H. Azmi, A.F. Hood, J.B. Travers, and M.C. Dinauer Enhanced cutaneous inflammatory reactions to Aspergillus fumigatus in a murine model of chronic granulomatous disease J. Invest. Dermatol. 118 2002 424 429
46. F.A. van de Loo, M.B. Bennink, O.J. Arntz, R.L. Smeets, E. Lubberts, L.A. Joosten, P.L. van Lent, C.J. Coenen-de Roo, S. Cuzzocrea, and B.H. Segal Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models Am. J. Pathol. 163 2003 1525 1537
47. I. Jaspers, E. Flescher, and L.C. Chen Ozone-induced IL-8 expression and transcription factor binding in respiratory epithelial cells Am. J. Physiol. 272 1997 L504 L511
48. S.A. Jones, M. Wolf, S. Qin, C.R. Mackay, and M. Baggiolini Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2 Proc. Natl. Acad. Sci. USA 93 1996 6682 6686
49. J.A. Lekstrom-Himes, D.B. Kuhns, W.G. Alvord, and J.I. Gallin Inhibition of human neutrophil IL-8 production by hydrogen peroxide and dysregulation in chronic granulomatous disease J. Immunol. 174 2005 411 417
50. A. Coxon, P. Rieu, F.J. Barkalow, S. Askari, A.H. Sharpe, U.H. von Andrian, M.A. Arnaout, and T.N. Mayadas A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation Immunity 5 1996 653 666
51. J.R. Brown, D. Goldblatt, J. Buddle, L. Morton, and A.J. Thrasher Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD) J. Leukoc. Biol. 73 2003 591 599
52. R.F. Fernandez-Boyanapalli, S.C. Frasch, K. McPhillips, R.W. Vandivier, B.L. Harry, D.W. Riches, P.M. Henson, and D.L. Bratton Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4 Blood 113 2009 2047 2055
53. S.C. Frasch, R.F. Fernandez-Boyanapalli, K.Z. Berry, C.C. Leslie, J.V. Bonventre, R.C. Murphy, P.M. Henson, and D.L. Bratton Signaling via Macrophage G2A enhances efferocytosis of dying neutrophils by augmentation of Rac activity J. Biol. Chem. 286 2011 12108 12122
54. S.C. Frasch, K.Z. Berry, R. Fernandez-Boyanapalli, H.S. Jin, C. Leslie, P.M. Henson, R.C. Murphy, and D.L. Bratton NADPH oxidase-dependent generation of lysophosphatidylserine enhances clearance of activated and dying neutrophils via G2A J. Biol. Chem. 283 2008 33736 33749
55. D. Sanmun, E. Witasp, S. Jitkaew, Y.Y. Tyurina, V.E. Kagan, A. Ahlin, J. Palmblad, and B. Fadeel Involvement of a functional NADPH oxidase in neutrophils and macrophages during programmed cell clearance: implications for chronic granulomatous disease Am. J. Physiol. Cell Physiol 297 2009 C621 C631
56. M.A. Stark, Y. Huo, T.L. Burcin, M.A. Morris, T.S. Olson, and K. Ley Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17 Immunity 22 2005 285 294
57. Y. Sun, and L.W. Oberley Redox regulation of transcriptional activators Free Radic. Biol. Med. 21 1996 335 348
58. S. Ghosh, and M. Karin Missing pieces in the NF-kappaB puzzle Cell 109 Suppl 2002 S81 S96
59. T.S. Blackwell, and J.W. Christman The role of nuclear factor-kappa B in cytokine gene regulation Am. J. Respir. Cell Mol. Biol. 17 1997 3 9
60. M. Karin, and A. Lin NF-kappaB at the crossroads of life and death Nat. Immunol. 3 2002 221 227
61. J.L. Luo, H. Kamata, and M. Karin IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy J. Clin. Invest. 115 2005 2625 2632
62. K. Asehnoune, D. Strassheim, S. Mitra, J.Y. Kim, and E. Abraham Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B J. Immunol. 172 2004 2522 2529
63. N.L. Reynaert, A. van der Vliet, A.S. Guala, T. McGovern, M. Hristova, C. Pantano, N.H. Heintz, J. Heim, Y.S. Ho, and D.E. Matthews Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta Proc. Natl. Acad. Sci. USA 103 2006 13086 13091
64. T.P. Dalton, H.G. Shertzer, and A. Puga Regulation of gene expression by reactive oxygen Annu. Rev. Pharmacol. Toxicol. 39 1999 67 101
65. J. Anrather, G. Racchumi, and C. Iadecola NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox J. Biol. Chem. 281 2006 5657 5667
66. M. Luengo-Blanco, C. Prando, J. Bustamante, W.C. Aragao-Filho, P.V. Pereira, J. Rehder, C. Padden, J.L. Casanova, P.E. Newburger, and A. Condino-Neto Essential role of nuclear factor-kappaB for NADPH oxidase activity in normal and anhidrotic ectodermal dysplasia leukocytes Blood 112 2008 1453 1460
67. L. Flohe, R. Brigelius-Flohe, C. Saliou, M.G. Traber, and L. Packer Redox regulation of NF-kappa B activation Free Radic. Biol. Med. 22 1997 1115 1126
68. I. Rusyn, M.B. Kadiiska, A. Dikalova, H. Kono, M. Yin, K. Tsuchiya, R.P. Mason, J.M. Peters, F.J. Gonzalez, and B.H. Segal Phthalates rapidly increase production of reactive oxygen species in vivo: role of Kupffer cells Mol. Pharmacol. 59 2001 744 750
69. I. Rusyn, S. Yamashina, B.H. Segal, R. Schoonhoven, S.M. Holland, R.C. Cattley, J.A. Swenberg, and R.G. Thurman Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators Cancer Res. 60 2000 4798 4803
70. H. Kono, I. Rusyn, M. Yin, E. Gabele, S. Yamashina, A. Dikalova, M.B. Kadiiska, H.D. Connor, R.P. Mason, and B.H. Segal NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease J. Clin. Invest. 106 2000 867 872
71. H. Yao, I. Edirisinghe, S.R. Yang, S. Rajendrasozhan, A. Kode, S. Caito, D. Adenuga, and I. Rahman Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice Am. J. Pathol. 172 2008 1222 1237
72. B.H. Segal, W. Han, J.J. Bushey, M. Joo, Z. Bhatti, J. Feminella, C.G. Dennis, R.R. Vethanayagam, F.E. Yull, and M. Capitano NADPH oxidase limits innate immune responses in the lungs in mice PLoS ONE 5 2010 e9631
73. K.L. Brown, J. Bylund, K.L. Macdonald, G.X. Song-Zhao, M.R. Elliott, R. Falsafi, R.E. Hancock, and D.P. Speert ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease Clin. Immunol. 129 2008 90 102
74. J. Bylund, K.L. Macdonald, K.L. Brown, P. Mydel, L.V. Collins, R.E. Hancock, and D.P. Speert Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B Eur. J. Immunol. 37 2007 1087 1096
75. K. Itoh, M. Mochizuki, Y. Ishii, T. Ishii, T. Shibata, Y. Kawamoto, V. Kelly, K. Sekizawa, K. Uchida, and M. Yamamoto Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)- prostaglandin j(2) Mol. Cell. Biol. 24 2004 36 45
76. T.O. Khor, M.T. Huang, K.H. Kwon, J.Y. Chan, B.S. Reddy, and A.N. Kong Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis Cancer Res. 66 2006 11580 11584
77. T.W. Kensler, N. Wakabayashi, and S. Biswal Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway Annu. Rev. Pharmacol. Toxicol. 2006
78. S. Dhakshinamoorthy, and A.K. Jaiswal Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene Oncogene 20 2001 3906 3917
79. A.T. Dinkova-Kostova, W.D. Holtzclaw, R.N. Cole, K. Itoh, N. Wakabayashi, Y. Katoh, M. Yamamoto, and P. Talalay Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants Proc. Natl. Acad. Sci. USA 99 2002 11908 11913
80. T. Rangasamy, J. Guo, W.A. Mitzner, J. Roman, A. Singh, A.D. Fryer, M. Yamamoto, T.W. Kensler, R.M. Tuder, and S.N. Georas Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice J. Exp. Med. 202 2005 47 59
81. S.B. Cullinan, J.D. Gordan, J. Jin, J.W. Harper, and J.A. Diehl The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase Mol. Cell. Biol. 24 2004 8477 8486
82. L.A. Higa, and H. Zhang Stealing the spotlight: CUL4-DDB1 ubiquitin ligase docks WD40-repeat proteins to destroy Cell Div 2 2007 5
83. A. Kobayashi, M.I. Kang, H. Okawa, M. Ohtsuji, Y. Zenke, T. Chiba, K. Igarashi, and M. Yamamoto Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2 Mol. Cell. Biol. 24 2004 7130 7139
84. G. Rachakonda, Y. Xiong, K.R. Sekhar, S.L. Stamer, D.C. Liebler, and M.L. Freeman Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3 Chem. Res. Toxicol. 21 2008 705 710
85. T. Ogura, K.I. Tong, K. Mio, Y. Maruyama, H. Kurokawa, C. Sato, and M. Yamamoto Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains Proc. Natl. Acad. Sci. USA 107 2010 2842 2847
86. H.C. Huang, T. Nguyen, and C.B. Pickett Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2 Proc. Natl. Acad. Sci. USA 97 2000 12475 12480
87. Thimmulappa, R.K., Scollick, C., Traore, K., Yates, M., Trush, M.A., Liby, K.T., Sporn, M.B., Yamamoto, M., Kensler, T.W., and Biswal, S. 2006. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide. Biochem. Biophys. Res. Commun.
88. T.E. Sussan, T. Rangasamy, D.J. Blake, D. Malhotra, H. El-Haddad, D. Bedja, M.S. Yates, P. Kombairaju, M. Yamamoto, and K.T. Liby Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice Proc. Natl. Acad. Sci. USA 106 2009 250 255
89. T. Rangasamy, C.Y. Cho, R.K. Thimmulappa, L. Zhen, S.S. Srisuma, T.W. Kensler, M. Yamamoto, I. Petrache, R.M. Tuder, and S. Biswal Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice J. Clin. Invest. 114 2004 1248 1259
90. Lugade, A.A., Vethanayagam, R.R., Nasirikenari, M., Bogner, P.N., Segal, B.H., Thanavala, Y. 2011. Nrf2 regulates chronic lung inflammation and B cell responses to non-typeable Haemophilus influenzae. Am. J. Respir. Cell Mol. Biol. (in press).
91. C.J. Harvey, R.K. Thimmulappa, S. Sethi, X. Kong, L. Yarmus, R.H. Brown, D. Feller-Kopman, R. Wise, and S. Biswal Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model Sci. Transl. Med. 3 2011 78ra32
92. I.T. Lee, S.W. Wang, C.W. Lee, C.C. Chang, C.C. Lin, S.F. Luo, and C.M. Yang Lipoteichoic acid induces HO-1 expression via the TLR2/MyD88/c-Src/NADPH oxidase pathway and Nrf2 in human tracheal smooth muscle cells J. Immunol. 181 2008 5098 5110
93. S. Papaiahgari, S.R. Kleeberger, H.Y. Cho, D.V. Kalvakolanu, and S.P. Reddy NADPH oxidase and ERK signaling regulates hyperoxia-induced Nrf2-ARE transcriptional response in pulmonary epithelial cells J. Biol. Chem. 279 2004 42302 42312
94. K.R. Sekhar, P.A. Crooks, V.N. Sonar, D.B. Friedman, J.Y. Chan, M.J. Meredith, J.H. Starnes, K.R. Kelton, S.R. Summar, and S. Sasi NADPH oxidase activity is essential for Keap1/Nrf2-mediated induction of GCLC in response to 2-indol-3-yl-methylenequinuclidin-3-ols Cancer Res. 63 2003 5636 5645
95. Y. Imai, K. Kuba, G.G. Neely, R. Yaghubian-Malhami, T. Perkmann, G. van Loo, M. Ermolaeva, R. Veldhuizen, Y.H. Leung, and H. Wang Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury Cell 133 2008 235 249
96. K. Sato, M.B. Kadiiska, A.J. Ghio, J. Corbett, Y.C. Fann, S.M. Holland, R.G. Thurman, and R.P. Mason In vivo lipid-derived free radical formation by NADPH oxidase in acute lung injury induced by lipopolysaccharide: a model of ARDS FASEB J 16 2002 1713 1720
97. X.P. Gao, T.J. Standiford, A. Rahman, M. Newstead, S.M. Holland, M.C. Dinauer, Q.H. Liu, and A.B. Malik Role of NADPH oxidase in the mechanism of lung neutrophil sequestration and microvessel injury induced by gram-negative sepsis: studies in p47phox-/- and gp91phox-/- mice J. Immunol. 168 2002 3974 3982
98. B.H. Segal, B.A. Davidson, A.D. Hutson, T.A. Russo, B.A. Holm, B. Mullan, M. Habitzruther, S.M. Holland, and P.R. Knight 3rd Acid aspiration-induced lung inflammation and injury are exacerbated in NADPH oxidase-deficient mice Am. J. Physiol. Lung Cell. Mol. Physiol 292 2007 L760 L768
99. L. Zhu, J. Pi, S. Wachi, M.E. Andersen, R. Wu, and Y. Chen Identification of Nrf2-dependent airway epithelial adaptive response to proinflammatory oxidant-hypochlorous acid challenge by transcription profiling Am. J. Physiol. Lung Cell. Mol. Physiol 294 2008 L469 477
100. C.G. Woods, J. Fu, P. Xue, Y. Hou, L.J. Pluta, L. Yang, Q. Zhang, R.S. Thomas, M.E. Andersen, and J. Pi Dose-dependent transitions in Nrf2-mediated adaptive response and related stress responses to hypochlorous acid in mouse macrophages Toxicol. Appl. Pharmacol. 238 2009 27 36
101. J. Sun Jang, S. Piao, Y.N. Cha, and C. Kim Taurine chloramine activates Nrf2, increases HO-1 expression and protects cells from death caused by hydrogen peroxide J. Clin. Biochem. Nutr. 45 2009 37 43
102. J. Pi, Q. Zhang, C.G. Woods, V. Wong, S. Collins, and M.E. Andersen Activation of Nrf2-mediated oxidative stress response in macrophages by hypochlorous acid Toxicol. Appl. Pharmacol. 226 2008 236 243
103. Davidson, B.A., Vethanayagam, R.R., Grimm, M.J., Mullan, B., Almyroudis, N.G., Vigil, C., Blackwell, T.S., Han, W., Freeman, M.L., Sporn, M.B., et al. 2011. Nrf2 is protective in neutrophil-mediated acute lung injury. American Thoracic Society (ATS) International Conference, Denver, CO (Abstract 20115).
104. B.H. Segal Aspergillosis N. Engl. J. Med. 360 2009 1870 1884
105. S. Siddiqui, V.L. Anderson, D.M. Hilligoss, M. Abinun, T.W. Kuijpers, H. Masur, F.G. Witebsky, Y.R. Shea, J.I. Gallin, and H.L. Malech Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease Clin. Infect. Dis 45 2007 673 681
106. E. Bignell, S. Negrete-Urtasun, A.M. Calcagno, H.N. Arst Jr., T. Rogers, and K. Haynes Virulence comparisons of Aspergillus nidulans mutants are confounded by the inflammatory response of p47phox-/- mice Infect. Immun. 73 2005 5204 5207
107. D.E. Morgenstern, M.A. Gifford, L.L. Li, C.M. Doerschuk, and M.C. Dinauer Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus J. Exp. Med. 185 1997 207 218
108. M. Schappi, C. Deffert, L. Fiette, G. Gavazzi, F. Herrmann, D. Belli, and K.H. Krause Branched fungal beta-glucan causes hyperinflammation and necrosis in phagocyte NADPH oxidase-deficient mice J. Pathol. 214 2008 434 444
109. M.J. Grimm, R.R. Vethanayagam, N.G. Almyroudis, D. Lewandowski, N. Rall, T.S. Blackwell, and B.H. Segal Role of NADPH oxidase in host defense against aspergillosis Med. Mycol. 49 Suppl. 1 2011 S144 S149
110. G.D. Brown, and S. Gordon Immune recognition. A new receptor for beta-glucans Nature 413 2001 36 37
111. M.G. Netea, N.A. Gow, C.A. Munro, S. Bates, C. Collins, G. Ferwerda, R.P. Hobson, G. Bertram, H.B. Hughes, and T. Jansen Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors J. Clin. Invest. 116 2006 1642 1650
112. O. Gross, A. Gewies, K. Finger, M. Schafer, T. Sparwasser, C. Peschel, I. Forster, and J. Ruland Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity Nature 442 2006 651 656
113. S. LeibundGut-Landmann, O. Gross, M.J. Robinson, F. Osorio, E.C. Slack, S.V. Tsoni, E. Schweighoffer, V. Tybulewicz, G.D. Brown, and J. Ruland Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 Nat. Immunol. 8 2007 630 638
114. N.C. Rogers, E.C. Slack, A.D. Edwards, M.A. Nolte, O. Schulz, E. Schweighoffer, D.L. Williams, S. Gordon, V.L. Tybulewicz, and G.D. Brown Syk-dependent cytokine induction by dectin-1 reveals a novel pattern recognition pathway for C type lectins Immunity 22 2005 507 517
115. V. Aimanianda, J. Bayry, S. Bozza, O. Kniemeyer, K. Perruccio, S.R. Elluru, C. Clavaud, S. Paris, A.A. Brakhage, and S.V. Kaveri Surface hydrophobin prevents immune recognition of airborne fungal spores Nature 460 2009 1117 1121
116. G.M. Gersuk, D.M. Underhill, L. Zhu, and K.A. Marr Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states J. Immunol. 176 2006 3717 3724
117. T.M. Hohl, H.L. Van Epps, A. Rivera, L.A. Morgan, P.L. Chen, M. Feldmesser, and E.G. Pamer Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display PLoS Pathog. 1 2005 e30
118. C. Steele, R.R. Rapaka, A. Metz, S.M. Pop, D.L. Williams, S. Gordon, J.K. Kolls, and G.D. Brown The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus PLoS Pathog. 1 2005 e42
119. H.S. Goodridge, C.N. Reyes, C.A. Becker, T.R. Katsumoto, J. Ma, A.J. Wolf, N. Bose, A.S. Chan, A.S. Magee, and M.E. Danielson Activation of the innate immune receptor dectin-1 upon formation of a 'phagocytic synapse' Nature 472 2011 471 475
120. S.M. Holland, and D.C. Vinh Yeast infections - human genetics on the rise N. Engl. J. Med. 361 2009 1798 1801
121. E.O. Glocker, A. Hennigs, M. Nabavi, A.A. Schaffer, C. Woellner, U. Salzer, D. Pfeifer, H. Veelken, K. Warnatz, and F. Tahami A homozygous CARD9 mutation in a family with susceptibility to fungal infections N. Engl. J. Med. 361 2009 1727 1735
122. B. Ferwerda, G. Ferwerda, T.S. Plantinga, J.A. Willment, A.B. van Spriel, H. Venselaar, C.C. Elbers, M.D. Johnson, A. Cambi, and C. Huysamen Human dectin-1 deficiency and mucocutaneous fungal infections N. Engl. J. Med. 361 2009 1760 1767
123. J.L. Werner, A.E. Metz, D. Horn, T.R. Schoeb, M.M. Hewitt, L.M. Schwiebert, I. Faro-Trindade, G.D. Brown, and C. Steele Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus J. Immunol. 182 2009 4938 4946
124. E. Zenaro, M. Donini, and S. Dusi Induction of Th1/Th17 immune response by Mycobacterium tuberculosis: role of dectin-1, mannose receptor, and DC-SIGN J. Leukoc. Biol. 86 2009 1393 1401
125. S. Manicassamy, R. Ravindran, J. Deng, H. Oluoch, T.L. Denning, S.P. Kasturi, K.M. Rosenthal, B.D. Evavold, and B. Pulendran Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity Nat. Med 15 2009 401 409
126. L. Romani, F. Fallarino, A. De Luca, C. Montagnoli, C. DAngelo, T. Zelante, C. Vacca, F. Bistoni, M.C. Fioretti, and U. Grohmann Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease Nature 451 2008 211 215
127. A. George-Chandy, I. Nordstrom, E. Nygren, I.M. Jonsson, J. Postigo, L.V. Collins, and K. Eriksson Th17 development and autoimmune arthritis in the absence of reactive oxygen species Eur. J. Immunol. 38 2008 1118 1126
128. R. Horvath, D. Rozkova, J. Lastovicka, A. Polouckova, P. Sedlacek, A. Sediva, and R. Spisek Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous disease Clin. Exp. Immunol. 166 2011 26 33
129. K. Lee, H.Y. Won, M.A. Bae, J.H. Hong, and E.S. Hwang Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b and Th/Treg cells Proc. Natl. Acad. Sci. USA 108 2011 9548 9553
130. S.S. De Ravin, K.A. Zarember, D. Long-Priel, K.C. Chan, S.D. Fox, J.I. Gallin, D.B. Kuhns, and H.L. Malech Tryptophan/kynurenine metabolism in human leukocytes is independent of superoxide and is fully maintained in chronic granulomatous disease Blood 116 2010 1755 1760
131. B. Jurgens, D. Fuchs, J. Reichenbach, and A. Heitger Intact indoleamine 2,3-dioxygenase activity in human chronic granulomatous disease Clin. Immunol. 137 2010 1 4
132. G.J. Maghzal, S.R. Thomas, N.H. Hunt, and R. Stocker Cytochrome b5, not superoxide anion radical, is a major reductant of indoleamine 2,3-dioxygenase in human cells J. Biol. Chem. 283 2008 12014 12025